Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01755000 · ClinicalTrials.gov registry record · NA
Study of Hypotensive Hematopoietic Malignancy Patients' USCOM Readings
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 69
- Enrollment target
NCT01755000 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 69 participants.
The verdict
NCT01755000, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 69 participants
- Enrollment target
Study Summary
The purpose of this study is to test how practical it is to use the Ultrasonic Cardiac Output Monitor (USCOM), an FDA-approved device, on oncology patients (specifically those with blood cancers). Additionally, the researchers will learn if the USCOM gives additional information about patients' conditions when their blood pressures drop and they are treated with intravenous fluids.
Interventions
- PROCEDURE USCOM scan
- PROCEDURE Fluid Bolus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2012-12 |
| Est. Completion | 2013-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01755000
The ClinicalTrials.gov registry entry for NCT01755000 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 69 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which USCOM scan is the first listed.
NCT01755000 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01755000 about?
NCT01755000 is a clinical study titled "Study of Hypotensive Hematopoietic Malignancy Patients' USCOM Readings". The purpose of this study is to test how practical it is to use the Ultrasonic Cardiac Output Monitor (USCOM), an FDA-approved device, on oncology patients (specifically those with blood cancers). Additionally, the researchers will learn if the USCOM gives additional information about patients' cond...
What is the current status of trial NCT01755000?
This trial is currently completed. It is a NA study. The enrollment target is 69 participants. The study started on 2012-12. Estimated completion is 2013-04.
What interventions are being tested in trial NCT01755000?
The interventions under investigation include: USCOM scan (PROCEDURE), Fluid Bolus (PROCEDURE).
Who is sponsoring clinical trial NCT01755000?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.